Acceleron Pharma reported $104.83M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 10036M 518M
Acceleron Pharma XLRN:US $ 104.83M 13.23M
Akebia Therapeutics AKBA:US $ 103.64M 28.61M
Alexion Pharmaceuticals ALXN:US $ 1000.3M 30.6M
Amgen AMGN:US $ 4.33B 1.37B
Arena Pharmaceuticals ARNA:US $ 194.48M 50.09M
Bayer BAYN:GR 9.25B 3.88B
Biomarin Pharmaceutical BMRN:US $ 461.96M 28.06M
Bluebird Bio BLUE:US $ 239.63M 8.68M
Clovis Oncology CLVS:US $ 95.38M 978K
Dicerna Pharmaceuticals DRNA:US $ 83.23M 1.64M
Eli Lilly And LLY:US $ 5296.8M 39.9M
Exelixis EXEL:US $ 276.8M 14.63M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
Johnson & Johnson JNJ:US $ 19.49B 2.84B
Karyopharm Therapeutics KPTI:US $ 81.5M 9.85M
Mirati Therapeutics MRTX:US $ 151.29M 12.89M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Pfizer PFE:US $ 16447M 3384M
Ptc Therapeutics PTCT:US $ 231.82M 16.65M
Puma Biotechnology PBYI:US $ 87.84M 32.73M
Regeneron Pharmaceuticals REGN:US $ 1605.6M 185.7M
Rigel Pharmaceuticals RIGL:US $ 41.33M 2.01M
Sangamo Biosciences SGMO:US $ 77M 427K
Tg Therapeutics TGTX:US $ 87.16M 8.12M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
United Therapeutics UTHR:US $ 216M 10.6M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M